(131)I-Labeled Anti-HER2 Nanobody for Targeted Radionuclide Therapy of HER2-Positive Breast Cancer

PURPOSE: The unique structure of nanobodies is advantageous for the development of radiopharmaceuticals for nuclear medicine. Nanobodies targeted to human epidermal growth factor receptor 2 (HER2) can be used as tools for the imaging and therapy of HER2-overexpressing tumors. In this study, we aimed...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Lingzhou, Gong, Jiali, Qi, Qinli, Liu, Changcun, Su, Hongxing, Xing, Yan, Zhao, Jinhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10094415/
https://www.ncbi.nlm.nih.gov/pubmed/37064291
http://dx.doi.org/10.2147/IJN.S399322

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10094415/
https://www.ncbi.nlm.nih.gov/pubmed/37064291
http://dx.doi.org/10.2147/IJN.S399322

Ejemplares similares